Literature DB >> 19053777

Type-II kinase inhibitor docking, screening, and profiling using modified structures of active kinase states.

Irina Kufareva1, Ruben Abagyan.   

Abstract

Type-II kinase inhibitors represent a class of chemicals that trap their target kinases in an inactive, so-called DFG-out state, occupying a hydrophobic pocket adjacent to the ATP binding site. These compounds are often more specific than those that target active DFG-in kinase conformations. Unfortunately, the discovery of novel type-II scaffolds presents a considerable challenge, partially because the lack of compatible kinase structures makes structure-based methods inapplicable. We present a computational protocol for converting multiple available DFG-in structures of various kinases (approximately 70% of mammalian structural kinome) into accurate and specific models of their type-II bound state. The models, described as deletion-of-loop Asp-Phe-Gly-in (DOLPHIN) kinase models, demonstrate exceptional performance in various inhibitor discovery applications, including compound pose prediction, screening, and in silico activity profiling. Given the abundance of the DFG-in structures, the presented approach opens possibilities for kinome-wide discovery of specific molecules targeting inactive kinase states.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19053777      PMCID: PMC2669721          DOI: 10.1021/jm8010299

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  47 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  Prediction of the binding energy for small molecules, peptides and proteins.

Authors:  M Schapira; M Totrov; R Abagyan
Journal:  J Mol Recognit       Date:  1999 May-Jun       Impact factor: 2.137

Review 3.  Protein kinases--the major drug targets of the twenty-first century?

Authors:  Philip Cohen
Journal:  Nat Rev Drug Discov       Date:  2002-04       Impact factor: 84.694

4.  The Uppsala Electron-Density Server.

Authors:  Gerard J Kleywegt; Mark R Harris; Jin Yu Zou; Thomas C Taylor; Anders Wählby; T Alwyn Jones
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

5.  Structural factors contributing to the Abl/Lyn dual inhibitory activity of 3-substituted benzamide derivatives.

Authors:  Tatsuya Horio; Tomohiro Hamasaki; Toshihiko Inoue; Tatsushi Wakayama; Shinsaku Itou; Haruna Naito; Tetsuo Asaki; Hiroki Hayase; Tomoko Niwa
Journal:  Bioorg Med Chem Lett       Date:  2007-03-03       Impact factor: 2.823

6.  Functional interrogation of the kinome using nucleotide acyl phosphates.

Authors:  Matthew P Patricelli; A Katrin Szardenings; Marek Liyanage; Tyzoon K Nomanbhoy; Min Wu; Helge Weissig; Arwin Aban; Doris Chun; Stephen Tanner; John W Kozarich
Journal:  Biochemistry       Date:  2007-01-16       Impact factor: 3.162

7.  Atomic property fields: generalized 3D pharmacophoric potential for automated ligand superposition, pharmacophore elucidation and 3D QSAR.

Authors:  Maxim Totrov
Journal:  Chem Biol Drug Des       Date:  2007-12-07       Impact factor: 2.817

8.  Kinase inhibition with BAY 43-9006 in renal cell carcinoma.

Authors:  Tanya Ahmad; Tim Eisen
Journal:  Clin Cancer Res       Date:  2004-09-15       Impact factor: 12.531

9.  Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl.

Authors:  Ellen Weisberg; Paul W Manley; Werner Breitenstein; Josef Brüggen; Sandra W Cowan-Jacob; Arghya Ray; Brian Huntly; Doriano Fabbro; Gabriele Fendrich; Elizabeth Hall-Meyers; Andrew L Kung; Jürgen Mestan; George Q Daley; Linda Callahan; Laurie Catley; Cara Cavazza; Mohammad Azam; Azam Mohammed; Donna Neuberg; Renee D Wright; D Gary Gilliland; James D Griffin
Journal:  Cancer Cell       Date:  2005-02       Impact factor: 31.743

10.  Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site.

Authors:  Christopher Pargellis; Liang Tong; Laurie Churchill; Pier F Cirillo; Thomas Gilmore; Anne G Graham; Peter M Grob; Eugene R Hickey; Neil Moss; Susan Pav; John Regan
Journal:  Nat Struct Biol       Date:  2002-04
View more
  56 in total

1.  Improved docking, screening and selectivity prediction for small molecule nuclear receptor modulators using conformational ensembles.

Authors:  So-Jung Park; Irina Kufareva; Ruben Abagyan
Journal:  J Comput Aided Mol Des       Date:  2010-05-09       Impact factor: 3.686

2.  Predicting flexible loop regions that interact with ligands: the challenge of accurate scoring.

Authors:  Matthew L Danielson; Markus A Lill
Journal:  Proteins       Date:  2011-11-09

Review 3.  Computational insights for the discovery of non-ATP competitive inhibitors of MAP kinases.

Authors:  Michael J Schnieders; Tamer S Kaoud; Chunli Yan; Kevin N Dalby; Pengyu Ren
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

4.  Role of Molecular Interactions and Protein Rearrangement in the Dissociation Kinetics of p38α MAP Kinase Type-I/II/III Inhibitors.

Authors:  Wanli You; Chia-En A Chang
Journal:  J Chem Inf Model       Date:  2018-04-16       Impact factor: 4.956

5.  Electrostatic mechanism of V600E mutation-induced B-Raf constitutive activation in colorectal cancer: molecular implications for the selectivity difference between type-I and type-II inhibitors.

Authors:  Tie Liu; Zhaoshun Wang; Peng Guo; Na Ding
Journal:  Eur Biophys J       Date:  2018-09-14       Impact factor: 1.733

6.  Application of shape-based and pharmacophore-based in silico screens for identification of Type II protein kinase inhibitors.

Authors:  Daniel Mucs; Richard A Bryce; Pascal Bonnet
Journal:  J Comput Aided Mol Des       Date:  2011-06-17       Impact factor: 3.686

7.  A novel mode of protein kinase inhibition exploiting hydrophobic motifs of autoinhibited kinases: discovery of ATP-independent inhibitors of fibroblast growth factor receptor.

Authors:  Sudharshan Eathiraj; Rocio Palma; Marscha Hirschi; Erika Volckova; Enkeleda Nakuci; Jennifer Castro; Chang-Rung Chen; Thomas C K Chan; Dennis S France; Mark A Ashwell
Journal:  J Biol Chem       Date:  2011-03-24       Impact factor: 5.157

8.  Can structural features of kinase receptors provide clues on selectivity and inhibition? A molecular modeling study.

Authors:  Sarangan Ravichandran; Brian T Luke; Jack R Collins
Journal:  J Mol Graph Model       Date:  2015-01-12       Impact factor: 2.518

9.  Insights from free-energy calculations: protein conformational equilibrium, driving forces, and ligand-binding modes.

Authors:  Yu-Ming M Huang; Wei Chen; Michael J Potter; Chia-En A Chang
Journal:  Biophys J       Date:  2012-07-17       Impact factor: 4.033

10.  Recipes for the selection of experimental protein conformations for virtual screening.

Authors:  Manuel Rueda; Giovanni Bottegoni; Ruben Abagyan
Journal:  J Chem Inf Model       Date:  2010-01       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.